RE:RE:That’s all the CEO can deliver $ 1.77 Hexo StockZenabis was reporting adjusted EBITDA positive numbers right up to the acquistion by HEXO. Post-acquistion we would be seeing that operation contining to sell product with less overhead as (as a minimum) the executive team has been removed. Other cost savings were noted by HEXO and can be reviewed by going through the news released by HEXO related to the purchase.
The reason why the Cannabis companies are not profitable right now (nor were back when they hit their all time highs in 2019) is due to their revenue not keeping pace with their expenses. Over time the revenues increase over the expenses and they turn profitable. Currently HEXO is on the road towards profitability at a pace faster than the other top producers within the sector with those competitors trading at much higher earnings multiplies (PS-Ratios)
Due to HEXOs shorter timeline to profitability and the lower PS-Ratio I see it worth the longer term bet for the largest ROI in the Canadian Cannabis Sector.
https://ycharts.com/companies/HEXO.TO/ps_ratio
quinlash wrote: HEXO will be reporting incremental sales on the Oct report due to its acquistion of Zenabis and having that deal close within the reporting period. Addional incremental sales from 48 North and Redecan will appear on the Dec report as their deals closed within that cooresponding reporting period.
HEXO has reported cost reduction and cost optimization targets / expectations on each of the deals with much of that information contained in the Redecan Investors Deck available on their website.
Try some research, you can rough out the numbers for yourself.
Q
- Long on HEXO
Mukulu20 wrote: $1.77 after all that acquisitions. Disgusting and shameful. What good is this CEO? Can't reduce cost nor increase revenue. Nothing.,